40307-1 |
Somatotropin^3.5H post dose arginine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post dose arginine |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
40307-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 3.5h p Arg SerPl-mCnc |
|
|
|
N |
|
3.5h p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.15 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
40308-9 |
Somatotropin^4H post dose arginine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --4 hours post dose arginine |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
40308-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH 4h p Arg SerPl-mCnc |
|
|
|
N |
|
4h p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.15 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
40309-7 |
Somatotropin^pre or post dose glucose |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucose |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
40309-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre/p Glc SerPl-mCnc |
|
|
|
N |
|
After; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; pre/p Glc; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.7 |
2.15 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
4031-1 |
Sotalol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Sotalol [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
4031-1 |
|
|
|
|
Both |
|
|
|
0 |
Sotalol Ur-mCnc |
|
|
|
Y |
|
Beta-cardone; Betapace; Betudes; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Solalex; Sotacor; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
40310-5 |
Cortisol^pre dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40310-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis pre Triple Bolus SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40311-3 |
Cortisol^15M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40311-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 15M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
15M p Triple Bolus; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40312-1 |
Cortisol^30M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40312-1 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 30M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 30M p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40313-9 |
Cortisol^45M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40313-9 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 45M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 45M p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40314-7 |
Cortisol^1H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40314-7 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 1h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p Triple Bolus; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40315-4 |
Cortisol^1.5H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40315-4 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 1.5h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p Triple Bolus; 1.5Hr; 17-Hydroxycorticosterone; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40316-2 |
Cortisol^2H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40316-2 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 2h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 17-Hydroxycorticosterone; 2 hours; 2h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40317-0 |
Cortisol^3H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40317-0 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis 3h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 3h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40318-8 |
Glucose^pre dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40318-8 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre Triple Bolus SerPl-sCnc |
|
|
|
N |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40319-6 |
Glucose^15M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40319-6 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 15M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
15M p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
4032-9 |
Sotalol |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Sotalol [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
4032-9 |
|
|
|
|
Both |
|
|
|
0 |
Sotalol 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Beta-cardone; Betapace; Betudes; DRUG/TOXICOLOGY; Drugs; Mass rate; mRate; QNT; Quan; Quant; Quantitative; Solalex; Sotacor; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ng/(24.h) |
|
|
|
0 |
40320-4 |
Glucose^30M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40320-4 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 30M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
30M p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40321-2 |
Glucose^45M post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40321-2 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 45M p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
45M p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40322-0 |
Glucose^1H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40322-0 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Triple Bolus; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40323-8 |
Glucose^2H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40323-8 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 2h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40324-6 |
Glucose^3H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
40324-6 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 3h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
3h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
40325-3 |
Testosterone^pre dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Testosterone [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40325-3 |
|
|
|
|
Observation |
|
|
|
0 |
Testost pre Triple Bolus SerPl-sCnc |
|
|
|
N |
|
Before; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40326-1 |
Testosterone^3H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Testosterone [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
40326-1 |
|
|
|
|
Observation |
|
|
|
0 |
Testost 3h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
3h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
40327-9 |
Triiodothyronine.free^pre dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
pmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
40327-9 |
|
|
|
|
Observation |
|
|
|
0 |
T3Free pre Triple Bolus SerPl-sCnc |
|
|
|
N |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Non-protein bound; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T3; T-3; T3Free; thyroid hormone; Total T3; Tri; Triodothyrne; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
40328-7 |
Triiodothyronine.free^2H post dose triple bolus |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
pmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
40328-7 |
|
|
|
|
Observation |
|
|
|
0 |
T3Free 2h p Triple Bolus SerPl-sCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Triple Bolus; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Non-protein bound; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; T3; T-3; T3Free; thyroid hormone; Total T3; Tri; Triodothyrne; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
40329-5 |
Prolactin^pre dose triple bolus |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Mass/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
ng/mL;ug/L |
|
|
|
|
|
|
CHAL |
|
40329-5 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin pre Triple Bolus SerPl-mCnc |
|
|
|
N |
|
Before; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |